Image

BARDA BP-I-23-001 H5 Influenza

Join our clinical trial for H5 flu research.

Recruiting
18 years and older
All
Phase 2

This study, funded by BARDA, is to test the safety and immune response of H5 flu vaccines. The flu vaccine is an inactivated monovalent influenza vaccine, meaning it targets one type of flu virus and is not live. The study uses different doses of the vaccine and tests them with substances called adjuvants (AS03 or MF59) that help the body build a better immune response. The study is randomized (participants are randomly assigned to different groups) and double-blind (neither participants nor most researchers know which group gets which treatment) to ensure fair results.

  • This study lasts until Day 203 and includes several visits and tests to check for safety and immune response.
  • Participants will receive two doses of the flu vaccine 21 days apart.
  • There are specific eligibility rules, such as age and health conditions, to join the study.

Safety checks include looking for side effects like soreness or fever after getting the vaccine. The study aims to see how well the vaccine works by measuring things like seroprotection rate (how much it protects you) and seroconversion rate (how many people develop a protective immune response). If you are healthy, over 18, and meet the criteria, you might consider participating. Compensation details are not mentioned, so check with the study coordinators for more information.

Study details
    Influenza

NCT06560151

Biomedical Advanced Research and Development Authority

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.